Tri-substituted pyrimidine compounds and their use as PDE10 inhibitors

Details for Australian Patent Application No. 2009287621 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Kawanishi, Eiji; Matsumura, Takehiko

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009287621

PCT Pub. Number WO2010/027097

Priority 61/094,166 04.09.08 US

Filing date 3 September 2009

Wipo publication date 11 March 2010

Acceptance publication date 20 September 2012

International Classifications

C07D 239/48 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 25/18 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

A61P 25/30 Drugs for disorders of the nervous system

C07D 241/42 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/027097 Priority application(s): WO2010/027097

20 September 2012 Application Accepted

  Published as AU-B-2009287621

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009287628-Concentrator Photovoltaic Module, and Method for Manufacturing Concentrator Photovoltaic Module

2009287565-Device and method for automatically preparing emulsion drug